Wealthspire Advisors, L.P. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 217 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
Wealthspire Advisors, L.P. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$39,000
+50.0%
2,1000.0%0.00%
+50.0%
Q4 2018$26,000
-25.7%
2,100
+13.9%
0.00%
-33.3%
Q3 2018$35,000
+45.8%
1,843
+5.7%
0.00%
+50.0%
Q2 2018$24,000
+380.0%
1,743
+149.0%
0.00%
Q1 2018$5,000
+66.7%
7000.0%0.00%
Q4 2017$3,0000.0%7000.0%0.00%
Q3 2017$3,0007000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders